Dosing Study of the Effects of Nebivolol on Blood Pressure in Black Patients With Mild to Moderate Hypertension
Clinical trial NCT00145236 · COMPLETED
Trial details
- NCT number
- NCT00145236
- Sponsor
- Mylan Bertek Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2001-11-01
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.